What is Zacks Research’s Forecast for BAX FY2026 Earnings?

Baxter International Inc. (NYSE:BAX) – Equities researchers at Zacks Research increased their FY2026 earnings per share estimates for shares of Baxter International in a report released on Thursday, August 20th. Zacks Research analyst Team now forecasts that the medical instruments supplier will earn $2.02 per share for the year, up from their prior estimate of $1.83. Zacks Research has a “Hold” rating on the stock. The consensus estimate for Baxter International’s current full-year earnings is $2.04 per share. Zacks Research also issued estimates for Baxter International’s FY2027 earnings at $2.00 EPS.

Baxter International (NYSE:BAX) last announced its quarterly earnings data on Thursday, July 30th. The medical instruments supplier reported $0.56 EPS for the quarter, beating the consensus estimate of $0.37 by $0.19. The business had revenue of $2.96 billion for the quarter, compared to the consensus estimate of $2.80 billion. Baxter International had a positive return on equity of 16.57% and a negative net margin of 9.27%.The business’s revenue was up 5.3% on a year-over-year basis. During the same period in the previous year, the business earned $0.59 earnings per share. Baxter International has set its FY 2026 guidance at 1.950-2.150 EPS.

Several other research analysts also recently weighed in on BAX. Weiss Ratings upgraded Baxter International from a “sell (d-)” rating to a “sell (d)” rating in a research note on Friday, July 31st. Wells Fargo & Company lifted their price objective on shares of Baxter International from $19.00 to $23.00 and gave the company an “equal weight” rating in a research report on Friday, July 31st. UBS Group boosted their target price on shares of Baxter International from $19.00 to $25.00 and gave the stock a “hold” rating in a report on Tuesday, July 28th. Stifel Nicolaus upped their target price on shares of Baxter International from $19.00 to $24.00 and gave the stock a “hold” rating in a research report on Tuesday, July 28th. Finally, Citigroup raised shares of Baxter International from a “sell” rating to a “neutral” rating and raised their target price for the company from $17.00 to $28.00 in a research note on Friday, July 31st. Two equities research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $22.45.

Baxter International Stock Down 0.8%

Shares of BAX opened at $26.27 on Monday. The business’s 50 day moving average is $23.86 and its 200 day moving average is $20.45. The company has a market capitalization of $13.58 billion, a PE ratio of -12.69, a price-to-earnings-growth ratio of 4.01 and a beta of 0.60. Baxter International has a 12-month low of $15.73 and a 12-month high of $30.00. The company has a current ratio of 1.95, a quick ratio of 1.32 and a debt-to-equity ratio of 1.39.

Baxter International Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, October 1st. Stockholders of record on Friday, August 28th will be paid a $0.01 dividend. The ex-dividend date of this dividend is Friday, August 28th. This represents a $0.04 annualized dividend and a dividend yield of 0.2%. Baxter International’s dividend payout ratio is currently -1.93%.

Hedge Funds Weigh In On Baxter International

Large investors have recently made changes to their positions in the company. Pzena Investment Management LLC purchased a new position in shares of Baxter International during the second quarter valued at approximately $1,392,098,000. Tocqueville Asset Management L.P. purchased a new stake in shares of Baxter International in the second quarter worth approximately $30,604,000. AMG National Trust Bank purchased a new stake in shares of Baxter International in the second quarter worth approximately $2,522,000. BlackRock Inc. bought a new stake in shares of Baxter International during the 2nd quarter worth approximately $1,744,874,000. Finally, Edmond DE Rothschild Holding S.A. bought a new stake in shares of Baxter International during the 2nd quarter worth approximately $51,958,000. 90.19% of the stock is owned by hedge funds and other institutional investors.

About Baxter International

Baxter International Inc is a global healthcare company that develops, manufactures and markets a broad portfolio of medical products, pharmaceutical therapies and biotechnology-based solutions. The company’s primary business activities are organized around renal care, medication delivery, acute therapies, pharmacy automation, surgical care and biotechnology. Baxter’s offerings are designed to support patient care in hospitals, dialysis centers, nursing homes and other healthcare facilities worldwide.

In the renal care segment, Baxter provides hemodialysis and peritoneal dialysis systems, water treatment equipment and related disposables, including dialyzers, bloodlines and catheters.